Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon

Diffuse skin reactions, commonly leading to discontinuation of the treatment, have been reported in patients with hepatitis C treated with interferon. They were not as yet described in patients treated with a newer formulation of interferon, namely, pegylated interferon (PegINF). A 37-year-old male...

Full description

Saved in:
Bibliographic Details
Main Authors: Piotr Milkiewicz, Colina Yim, Isabelle Pache, J Heathcote
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2005/298403
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850210667367235584
author Piotr Milkiewicz
Colina Yim
Isabelle Pache
J Heathcote
author_facet Piotr Milkiewicz
Colina Yim
Isabelle Pache
J Heathcote
author_sort Piotr Milkiewicz
collection DOAJ
description Diffuse skin reactions, commonly leading to discontinuation of the treatment, have been reported in patients with hepatitis C treated with interferon. They were not as yet described in patients treated with a newer formulation of interferon, namely, pegylated interferon (PegINF). A 37-year-old male patient with viral hepatitis B developed a diffuse urticarial skin reaction during treatment with two different forms of PegINF. Despite the skin reaction, the treatment was continued, and the patient responded very well to topical steroids and antihistamines. The present report suggests that despite the severity of reaction, withdrawal of PegINF may not always be required because this particular skin reaction responded well to symptomatic treatment. This is important, because discontinuation of PegINF may decrease the chance of achieving a sustained virological response in patients with viral hepatitis.
format Article
id doaj-art-90be35db27344f7d9a01a1422b563d27
institution OA Journals
issn 0835-7900
language English
publishDate 2005-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-90be35db27344f7d9a01a1422b563d272025-08-20T02:09:44ZengWileyCanadian Journal of Gastroenterology0835-79002005-01-01191167767810.1155/2005/298403Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated InterferonPiotr Milkiewicz0Colina Yim1Isabelle Pache2J Heathcote3Toronto Western Hospital, University Health Network, Toronto, Ontario, CanadaToronto Western Hospital, University Health Network, Toronto, Ontario, CanadaToronto Western Hospital, University Health Network, Toronto, Ontario, CanadaToronto Western Hospital, University Health Network, Toronto, Ontario, CanadaDiffuse skin reactions, commonly leading to discontinuation of the treatment, have been reported in patients with hepatitis C treated with interferon. They were not as yet described in patients treated with a newer formulation of interferon, namely, pegylated interferon (PegINF). A 37-year-old male patient with viral hepatitis B developed a diffuse urticarial skin reaction during treatment with two different forms of PegINF. Despite the skin reaction, the treatment was continued, and the patient responded very well to topical steroids and antihistamines. The present report suggests that despite the severity of reaction, withdrawal of PegINF may not always be required because this particular skin reaction responded well to symptomatic treatment. This is important, because discontinuation of PegINF may decrease the chance of achieving a sustained virological response in patients with viral hepatitis.http://dx.doi.org/10.1155/2005/298403
spellingShingle Piotr Milkiewicz
Colina Yim
Isabelle Pache
J Heathcote
Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
Canadian Journal of Gastroenterology
title Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
title_full Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
title_fullStr Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
title_full_unstemmed Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
title_short Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
title_sort diffuse skin reaction in patient with hepatitis b treated with two different formulations of pegylated interferon
url http://dx.doi.org/10.1155/2005/298403
work_keys_str_mv AT piotrmilkiewicz diffuseskinreactioninpatientwithhepatitisbtreatedwithtwodifferentformulationsofpegylatedinterferon
AT colinayim diffuseskinreactioninpatientwithhepatitisbtreatedwithtwodifferentformulationsofpegylatedinterferon
AT isabellepache diffuseskinreactioninpatientwithhepatitisbtreatedwithtwodifferentformulationsofpegylatedinterferon
AT jheathcote diffuseskinreactioninpatientwithhepatitisbtreatedwithtwodifferentformulationsofpegylatedinterferon